Abstract
Porphyrias are a group of metabolic diseases caused by a loss of functionality in the enzymes involved in the biosynthesis of the heme group. They are classified according to the main clinical manifestations (neurological or cutaneous) and the tissue where the enzymatic alteration occurs (liver or bone marrow). Thus, those that affect the liver are called hepatic porphyria
Keywords
Givosiran; Acute hepatic porphyria; Minority disease
Bibliographic citation
Programa d'Harmonització Farmacoterapèutica. Givosiran per al tractament de la porfíria hepàtica aguda. Barcelona: Servei Català de la Salut; 2021.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/7365This item appears in following collections
The following license files are associated with this item: